Neuroimmune modulation mediated by IL-6: A potential target for the treatment of ischemia-induced ventricular arrhythmias

Heart Rhythm. 2024 May;21(5):610-619. doi: 10.1016/j.hrthm.2023.12.020. Epub 2023 Dec 30.

Abstract

Background: Neural remodeling in the left stellate ganglion (LSG), as mediated by neuroimmune reactions, promotes cardiac sympathetic nerve activity (SNA) and thus increases the incidence of ventricular arrhythmias (VAs). Interleukin-6 (IL-6) is an important factor of the neuroimmune interaction.

Objective: The present study explored the effects of IL-6 on LSG hyperactivity and the incidence of VAs.

Methods: Eighteen beagles were randomly allocated to a control group (saline with myocardial infarction [MI], n = 6), adeno-associated virus (AAV) group (AAV with MI, n = 6), and IL-6 group (overexpression of IL-6 via AAV vector with MI, n = 6). Ambulatory electrocardiography was performed before and 30 days after AAV microinjection into the LSG. LSG function and ventricular electrophysiology were assessed at 31 days after surgery, and a canine MI model was established. Samples of the LSG were collected for immunofluorescence staining and molecular biological evaluation. Blood samples and 24-hour Holter data were obtained from 24 patients with acute MI on the day after they underwent percutaneous coronary intervention to assess the correlation between IL-6 levels and SNA.

Results: IL-6 overexpression increased cardiac SNA and worsened postinfarction VAs. Furthermore, sustained IL-6 overexpression enhanced LSG function, promoted expression of nerve growth factor, c-fos, and fos B in the LSG, and activated the signal transducer and activator of transcription 3/regulator of G protein signalling 4 signaling pathway. Clinical sample analysis revealed a correlation between serum IL-6 levels and heart rate variability frequency domain index as well as T-wave alternans.

Conclusion: IL-6 levels are correlated with cardiac SNA. Chronic overexpression of IL-6 mediates LSG neural remodeling through the signal transducer and activator of transcription 3/regulator of G protein signalling 4 signaling pathway, elevating the risk of VA after MI.

Keywords: Cardiac sympathetic nervous system; IL-6; Left stellate ganglion; Neuroimmune; Ventricular arrhythmias.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / etiology
  • Disease Models, Animal*
  • Dogs
  • Electrocardiography, Ambulatory / methods
  • Humans
  • Interleukin-6* / metabolism
  • Male
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / physiopathology
  • Neuroimmunomodulation / physiology
  • Stellate Ganglion* / metabolism
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiopathology
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / metabolism
  • Tachycardia, Ventricular / physiopathology
  • Tachycardia, Ventricular / therapy

Substances

  • Interleukin-6